At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Nanodropper +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of the Nanodropper Device on Pupillary Dilation
In Brief
A clinical study evaluating Nanodropper and Standard Eye Dropper for Dilation. Completed, enrolled 50 participants across 1 site.
Detailed Summary
Prescription eye drop bottles elute drops that exceed the capacity of the human eye by five times. This study describes performing in clinic dilation using a novel solution for combating medical waste with Nanodropper, an eye drop bottle adapter that creates smaller eye drops.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDilation
CountriesUnited States
CollaboratorsNanodropper, Inc.
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJul 2021
Primary CompletionNov 2021
First PostedMar 2022
TodayJul 2026
First PostedMar 10, 2022
Enrollment StartJul 29, 2021
Primary CompletionNov 19, 2021
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 4.3 years ago
Interventions
Nanodropperdevice
Device used for administering eye drops
Standard Eye Dropperdevice
Standard Eye Dropper used for administering eye drops